{"id":"CHEMBL1096979","canonicalSmiles":"NC(CO)C(=O)NNCc1ccc(O)c(O)c1O","inchiKey":"BNQDCRGUHNALGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENSERAZIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benserazide","Benserazide (as hydrochloride)","Benserazide hcl","Benserazide hydrochloride","NSC-755907","RO 4-4602","RO-4-4602","Serazide"],"crossReferences":{"PubChem":["174006784","90341370"],"Wikipedia":["Benserazide"],"drugbank":["DB12783"],"chEBI":["64187"]},"childChemblIds":["CHEMBL1255778"],"linkedTargets":{"rows":["ENSG00000132437"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180","EFO_0004270"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1160523","canonicalSmiles":"O=P(O)(O)OCCCc1c[nH]c2ccc(F)cc12","inchiKey":"YVYGGBFCYXRNKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160523","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160756","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"LVZDQVATAQEMCX-NSOVKSMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160756","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03591"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1175","canonicalSmiles":"CNCC[C@H](Oc1cccc2ccccc12)c1cccs1","inchiKey":"ZEUITGRIYCTCEM-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DULOXETINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cymbalta","Duloxetine","LY-248686","LY248686"],"crossReferences":{"DailyMed":["duloxetine%20hydrochloride"],"PubChem":["124893161","26719725","26757978","49681583"],"Wikipedia":["Duloxetine"],"drugbank":["DB00476"],"chEBI":["36795"]},"childChemblIds":["CHEMBL1200328"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0002970","MONDO_0005090","MONDO_0001583","EFO_0005687","EFO_0004262","MONDO_0002009","EFO_0000555","HP_0000726","EFO_0000401","EFO_1001951","EFO_0009562","EFO_1000783","MONDO_0005277","MONDO_0002050","HP_0030834","MONDO_0005180","EFO_0003100","EFO_0000712","EFO_0004616","EFO_0003761","HP_0003419","EFO_0004244","EFO_1000789","EFO_0004701","HP_0008419","MONDO_0007079","EFO_0005230","EFO_0000400","EFO_0004242","EFO_0005762","EFO_0003888","EFO_0006788","HP_0012532","EFO_0000677","EFO_0001358","HP_0003418","EFO_0010445","EFO_0003843","EFO_0007169","HP_0003326","EFO_0008623","EFO_1001892","HP_0030839","MONDO_0005301","HP_0000020","MONDO_0005178","EFO_0004540"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 8 approved and 35 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200627","canonicalSmiles":"O=C1CCO1","inchiKey":"VEZXCJBBBCKRPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIOLACTONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaprone"],"synonyms":[".beta.-propiolactone","Beta-propiolactone","NSC-21626","Propiolactone"],"crossReferences":{"PubChem":["144204577","17389751"],"Wikipedia":["Alpha-Propiolactone","Beta-Propiolactone"],"drugbank":["DB09348"],"chEBI":["49073"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200680","canonicalSmiles":"S=[Se]=S","inchiKey":"JNMWHTHYDQTDQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENIUM SULFIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exsel","Lenium","Selenium sulfide","Selsun"],"synonyms":["Seledruff","Selenii disulfidum","Selenium disulfide","Selenium sulfide","Selenium sulfide (ses(sub 2))","Selenium sulfide, micronized","Selenium sulphide (ses2)","Selenium sulphide, micronized"],"crossReferences":{"DailyMed":["selenium%20sulfide"],"Wikipedia":["Selenium_disulfide"],"drugbank":["DB00971"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and has 4 approved and 19 investigational indications."}
{"id":"CHEMBL1200692","canonicalSmiles":"CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"UQGKUQLKSCSZGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OLMESARTAN MEDOXOMIL","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benicar","Olmesartan medoxomil","Olmetec"],"synonyms":["CS-866","NSC-758924","Olmesartan medoxomil"],"crossReferences":{"DailyMed":["olmesartan%20medoxomil"],"PubChem":["144204998","26748978"]},"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0003086","MONDO_0001134","MONDO_0021661","EFO_0003144","EFO_0000401","EFO_0000712","HP_0000093","EFO_0000612","EFO_0000319","MONDO_0002462","EFO_0000400","EFO_0000537"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 6 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200819","canonicalSmiles":"CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC.Cl","inchiKey":"GDWDBGSWGNEMGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTICAINE HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1093","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Septanest","Septocaine","Ultracaine"],"synonyms":["40 045","Articaine hcl","Articaine hydrochloride","Carticaine hydrochloride","HOE 045","HOE-045","HOE-40045","Ubistesine","Ultracain"],"crossReferences":{"DailyMed":["articaine%20hydrochloride"],"PubChem":["144204160","170464825","56463593"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000649"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL1200851","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2.[Br-]","inchiKey":"FUFVKLQESJNNAN-RIMUKSHESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMATROPINE METHYLBROMIDE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201235","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Equipin","Homapin","Homapin-10","Homapin-5"],"synonyms":["Homatropine methylbromide","Homatropini methylbromidum","NSC-34399","NSC-757048"],"crossReferences":{"DailyMed":["homatropine%20methylbromide"],"Wikipedia":["Methylhomatropine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1943 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1200875","canonicalSmiles":"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl","inchiKey":"XOEVKNFZUQEERE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVOXATE HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1493","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flavoxate hydrochloride","Urispas","Urispas 200"],"synonyms":["DW-61","Flavoxate","Flavoxate hcl","Flavoxate hydrochloride","NSC-114649"],"crossReferences":{"DailyMed":["flavoxate%20hydrochloride"],"PubChem":["144204088","170466285"],"chEBI":["5089"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000171408","ENSG00000205268","ENSG00000113231","ENSG00000073417","ENSG00000184588"],"count":8},"linkedDiseases":{"rows":["EFO_0003103","EFO_0003901","EFO_0003830","EFO_0003878"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 4 approved indications."}
{"id":"CHEMBL1201073","canonicalSmiles":"O=C(O)[C@H](S)[C@H](S)C(=O)O","inchiKey":"ACTRVOBWPAIOHC-XIXRPRMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCIMER","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chemet","DMSA","Dim-Sa","Dimercaptosuccinic Acid"],"synonyms":["DIM-SA","DMS-A","DMSA","Meso-2,3-dimercaptosuccinic acid","RO 1-7977","Succimer"],"crossReferences":{"DailyMed":["succimer"],"Wikipedia":["Dimercaptosuccinic_acid"],"drugbank":["DB00566"],"chEBI":["63623"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 5 investigational indications."}
{"id":"CHEMBL1201099","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O=P(O)(O)O","inchiKey":"JPGKFBXFEQWCAI-CCLYOLAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CODEINE PHOSPHATE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ambenyl cough syrup","Bepro","Colrex compound","Evacode","Galcodine"],"synonyms":["Codeine phosphate","Codeine phosphate anhydrous","Codeine phosphate bp","Codeine phosphate cii","Codeine phosphate hemihydrate","Codeine phosphate hydrate","Codeini phosphas","Methylmorphine"],"crossReferences":{"DailyMed":["codeine%20phosphate"]},"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0003890","EFO_0010282","HP_0012735","EFO_0000764","HP_0000175","HP_0003394","EFO_0003843"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201132","canonicalSmiles":"Cl.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314","inchiKey":"YZLZPSJXMWGIFH-BCXQGASESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NALBUPHINE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL895","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nalbuphine","Nalbuphine hydrochloride","Nubain"],"synonyms":["EN-2234A","NSC-757829","Nalbufine hydrochloride","Nalbuphine hcl","Nalbuphine hydrochloride"],"crossReferences":{"DailyMed":["nalbuphine%20hydrochloride"],"PubChem":["56463337"],"chEBI":["7455"]},"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0000989","MONDO_0026045","EFO_0005323","MONDO_0005271","MONDO_0000870","HP_0000175","EFO_0000222","EFO_0009267","EFO_0003843","HP_0000713","HP_0003040","EFO_0001421","EFO_0005611","EFO_1001250"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for pain and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201256","canonicalSmiles":"COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC","inchiKey":"FEZBIKUBAYAZIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOBENZAMIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ametik damla","Trimethobenzamide"],"crossReferences":{"DailyMed":["trimethobenzamide%20hydrochloride"],"PubChem":["11112414"],"Wikipedia":["Trimethobenzamide"],"drugbank":["DB00662"],"chEBI":["27796"]},"childChemblIds":["CHEMBL1200887"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for allergic disease and post operative nausea and vomiting and has 1 investigational indication."}
{"id":"CHEMBL1213420","canonicalSmiles":"CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O","inchiKey":"OEHFRZLKGRKFAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROXICAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Droxicam"],"crossReferences":{"drugbank":["DB09215"],"chEBI":["76133"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1230144","canonicalSmiles":"Cc1ccc2c(c1)c1c(n2C[C@@H](O)CNC2CCCCC2)CCCC1","inchiKey":"AXYFCRIRLKSCRR-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230144","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07061"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231562","canonicalSmiles":"CCCc1oc(CCC(=O)O)c(C(=O)O)c1C","inchiKey":"WMCQWXZMVIETAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231562","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07517"],"chEBI":["41254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233322","canonicalSmiles":"Nc1nc2c(c(=O)[nH]1)N=C(CO)CN2","inchiKey":"CQQNNQTXUGLUEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233322","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02119"],"chEBI":["17083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233940","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cc3ccccc3o2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O","inchiKey":"AOMZDQMIOCTPQP-QHQMVRJISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L 756423","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L 756423","L-756423"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1235432","canonicalSmiles":"NCc1c[nH]c2nc(N)[nH]c(=O)c12","inchiKey":"MEYMBLGOKYDGLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235432","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03304"],"chEBI":["45126"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235722","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"KTVPXOYAKDPRHY-TXICZTDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5'-Phosphoribose","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-Phosphoribose"],"crossReferences":{"drugbank":["DB04352"],"chEBI":["45425"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1350","canonicalSmiles":"O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O","inchiKey":"DKJJVAGXPKPDRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILUDRONIC ACID","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Skelid"],"synonyms":["SR 41319","SR-41319","Skelid","Tiludronate","Tiludronic Acid","Tiludronic acid"],"crossReferences":{"Wikipedia":["Tiludronic_acid"],"drugbank":["DB01133"],"chEBI":["9598"]},"childChemblIds":["CHEMBL1200448"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for bone disease and has 1 investigational indication."}
{"id":"CHEMBL136497","canonicalSmiles":"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1","inchiKey":"ATCGGEJZONJOCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRSOGLADINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irsogladine","Irsogladine maleate","NSC-759836"],"crossReferences":{"PubChem":["29216078"],"drugbank":["DB13056"]},"childChemblIds":["CHEMBL1712923","CHEMBL3198346"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1434","canonicalSmiles":"CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"DYKFCLLONBREIL-KVUCHLLUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINOCYCLINE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Minocycline"],"crossReferences":{"DailyMed":["minocycline%20hydrochloride"],"PubChem":["144207192"],"Wikipedia":["Minocycline"],"drugbank":["DB01017"],"chEBI":["50694"]},"childChemblIds":["CHEMBL1200881"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 9 approved and 65 investigational indications."}
{"id":"CHEMBL1437","canonicalSmiles":"NC[C@H](O)c1ccc(O)c(O)c1","inchiKey":"SFLSHLFXELFNJZ-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOREPINEPHRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-noradrenaline","Levophed","NSC-757246","Nor adrenalin","Norepinephrine","R-norepinephrine"],"crossReferences":{"DailyMed":["norepinephrine%20bitartrate"],"PubChem":["144212261","26754493","26754494","29215339","50109852","50109853","57288371","90341660"],"Wikipedia":["Norepinephrine"],"drugbank":["DB00368"],"chEBI":["18357"]},"childChemblIds":["CHEMBL1356607","CHEMBL3273169","CHEMBL2311152","CHEMBL3248963","CHEMBL2130595","CHEMBL1434513"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0004610","EFO_0003888","EFO_0006859","EFO_0011061","EFO_0003777","EFO_0006834","HP_0002140","EFO_0005207","EFO_0005252","EFO_0001358","MONDO_0043771","EFO_0000319","EFO_0001073","HP_0100806","HP_0000083","MP_0001845","HP_0100543","EFO_0600064","MONDO_0002050","EFO_0003144","EFO_0002497","EFO_0007450","MONDO_0043510","HP_0031273","EFO_0005251"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 approved and 18 investigational indications."}
{"id":"CHEMBL154111","canonicalSmiles":"O=C(Oc1ccccc1C(=O)O)c1ccccc1O","inchiKey":"WVYADZUPLLSGPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SALSALATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Disalcid"],"synonyms":["Disalicyclic acid","NSC-49171","Salicylsalicylic acid","Salsalate","Sasapyrine"],"crossReferences":{"PubChem":["144205101","170465545","26750031"],"drugbank":["DB01399"],"chEBI":["9014"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for fever and pain and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1582","canonicalSmiles":"C[C@@H]1C[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]32)CC1=O","inchiKey":"IKXILDNPCZPPRV-RFMGOVQKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROMOSTANOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dromostanolone"],"crossReferences":{"Wikipedia":["Drostanolone"],"drugbank":["DB00858"],"chEBI":["34838"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL160","canonicalSmiles":"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C","inchiKey":"PMATZTZNYRCHOR-CGLBZJNRSA-N","drugType":"Protein","blackBoxWarning":true,"name":"CYCLOSPORINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capimune","Capsorin","Cequa","Cyclosporine","Deximune","Gengraf","Ikervis","Neoral","Optimmune","Restasis","Restasis multidose","Sandimmun","Sandimmune","Sangcya","Vanquoral","Verkazia"],"synonyms":["27-400","ANTIBIOTIC S-7481F1","Atopica","Ciclosporin","Ciclosporin a","Ciclosporinum","Cyclosporin","Cyclosporin a","Cyclosporine","Cyclosporine a","Cyclosporine microemulsion","Cyclosporine, modified","Equoral","Mitogard","NSC-290193","Neoplanta","Neurostat","OL-27-400","Ramihyphin a","SANG-35","SDZ-OXL-400","Zinograf me"],"crossReferences":{"DailyMed":["cyclosporine"],"PubChem":["11532934","144204218","144212166","170466812","26757675","56422786"],"TG-GATEs":["142"],"Wikipedia":["Ciclosporin"],"drugbank":["DB00091"],"chEBI":["4031"]},"linkedTargets":{"rows":["ENSG00000196262"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","EFO_0000681","EFO_0005952","MONDO_0018896","EFO_1001951","EFO_0000339","EFO_0003884","EFO_0007157","EFO_0000676","EFO_0000400","Orphanet_379","EFO_0000198","MONDO_0013730","Orphanet_79213","MONDO_0019465","EFO_0009449","EFO_1000906","HP_0000964","EFO_0001642","EFO_0004286","HP_0009926","MONDO_0008315","Orphanet_567","EFO_1000760","EFO_1001231","EFO_1001365","MONDO_0009453","MONDO_0020290","EFO_0000678","EFO_0000574","EFO_0001378","EFO_0000341","EFO_0001054","EFO_0000516","Orphanet_231214","EFO_1000550","EFO_0004214","EFO_0003086","Orphanet_84","EFO_0007183","EFO_0007451","Orphanet_104","MONDO_0007254","EFO_1001413","Orphanet_790","MONDO_0003541","EFO_0005676","EFO_0003966","MONDO_0002158","MONDO_0002898","EFO_1001478","EFO_0000183","EFO_0007527","EFO_1000388","EFO_0000616","EFO_0000694","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_0004198","EFO_0000319","MONDO_0000870","EFO_0003818","MONDO_0019469","EFO_0004599","EFO_0004220","EFO_0000649","EFO_0000764","EFO_0006927","EFO_0007359","MONDO_0002367","EFO_0007141","MONDO_0018906","MONDO_0043510","EFO_0000557","EFO_0000763","MONDO_0005148","EFO_0009492","EFO_0000729","Orphanet_309015","MONDO_0000873","EFO_0003777","EFO_0003780","MONDO_0000956","Orphanet_848","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0000544","EFO_0000389","MONDO_0019088","EFO_0000182","EFO_0000330","EFO_0000783","MONDO_0015540","MONDO_0004768","EFO_1000785","EFO_0004276","EFO_1001156","EFO_0009441","EFO_0005761","EFO_0000220","EFO_0002687","HP_0001919","MONDO_0008170","EFO_0004236","MONDO_0044881","EFO_0009708","MP_0001845","EFO_0006926","MONDO_0100096","MONDO_0021193","EFO_0002428","EFO_1001051","EFO_0000699","EFO_1000102","Orphanet_232","EFO_1000965","MONDO_0015686","EFO_0008507","EFO_0000274","HP_0001915","EFO_1001469","EFO_1001264","EFO_1002048","Orphanet_91378","EFO_1000690","EFO_0005531","MONDO_0001475","EFO_0004254","EFO_0003047","EFO_0009609","EFO_0000685","Orphanet_666","EFO_0000621","EFO_0000311","MONDO_0001705","EFO_0000095","MONDO_0005147","EFO_0001421","EFO_0008583","EFO_1000560","EFO_0000612","MONDO_0020077","EFO_0003833","EFO_0000691"],"count":147},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 6 approved and 118 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL161381","canonicalSmiles":"Nc1nc(=O)n(C2CSC(CO)O2)cc1F","inchiKey":"XQSPYNMVSIKCOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMTRICITABINE, (+/-)-","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emtricitabine, (+/-)-","Ftc, dl-","PSI-5004","Racivir"],"crossReferences":{"PubChem":["174006968"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL165084","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"SQVRNKJHWKZAKO-PFQGKNLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL165084","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576699"],"Wikipedia":["Neuraminic_acid"],"drugbank":["DB04265"],"chEBI":["45744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1652606","canonicalSmiles":"Cc1oc(=O)oc1COC(=O)N1CC[C@@H](N2CC/C(=C\\C3=C(C(=O)O)N4C(=O)[C@@H](NC(=O)/C(=N/O)c5nsc(N)n5)[C@H]4SC3)C2=O)C1","inchiKey":"HFTSMHTWUFCYMJ-FDNJTQOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOBIPROLE MEDOCARIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAL-5788","BAL-5788-001","BAL5788","BAL5788-001","Ceftobiprole medocaril","Ceftobiprole medocaril sodium","Ceftobiprole medocaril sodium salt","RO 65-5788","RO-65-5788","RO-655788"],"childChemblIds":["CHEMBL4297101"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1675","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C","inchiKey":"VYGQUTWHTHXGQB-FFHKNEKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VITAMIN A PALMITATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afaxin","Alphalin","Aquasol a","Del-vi-a","Vi-dom-a","Vitamin a","Vitamin a palmitate","Vitamin a solubilized"],"synonyms":["All-(e)-retinol palmitate","NSC-758478","Retinol, hexadecanoate","Retinol, palmitate, all-trans","Retinyl palmitate","Vitamin a palmitate"],"crossReferences":{"PubChem":["144207001","144213325","26748810","57260141"],"chEBI":["17616"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1743083","drugType":"Antibody","blackBoxWarning":false,"name":"TREGALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BT-061","Tregalizumab"],"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1001494","MONDO_0005271","MONDO_0004784"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL175633","canonicalSmiles":"CC(C)N1CCN(c2ccc(N3CCN(c4ccc(OC[C@H]5OC[C@](Cn6cncn6)(c6ccc(F)cc6F)O5)cc4)CC3)cc2)C1=O","inchiKey":"AEKNYBWUEYNWMJ-QWOOXDRHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMICONAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pramiconazole","R-126638","R126638"],"crossReferences":{"drugbank":["DB06295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1763","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O","inchiKey":"DMDGGSIALPNSEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROFLUMETHIAZIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diucardin","Hydrenox","Hydroflumethiazide","Saluron"],"synonyms":["Hydroflumethiazide","NSC-44627"],"crossReferences":{"PubChem":["11112295","144203973","170465082","26747027","56422879","855883"],"Wikipedia":["Hydroflumethiazide"],"drugbank":["DB00774"],"chEBI":["5784"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1765508","canonicalSmiles":"O=C(N[C@H]1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2ccc(Cl)cc2)C1)c1ccnc2ccccc12","inchiKey":"NXLUTEDAEFXMQR-BJKOFHAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPERGUALIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antibiotic bmg 162af2","Antibiotic bmg-162af2","Ls-74246","Spergualin"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL180022","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C","inchiKey":"JWNPDZNEKVCWMY-VQHVLOKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERATINIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CDP-820","HKI-272","Neratinib","WAY-179272"],"crossReferences":{"DailyMed":["neratinib%20maleate"],"PubChem":["124950160"],"Wikipedia":["Neratinib"],"drugbank":["DB11828"]},"childChemblIds":["CHEMBL3989921"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","MONDO_0008170","MONDO_0007254","EFO_0000313","EFO_0000305","EFO_0003060","EFO_1001951","MONDO_0001056","EFO_0000304","EFO_1001480","EFO_0000339","EFO_0003968","EFO_0005537","EFO_0000673","EFO_0000519"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL1829174","canonicalSmiles":"Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1","inchiKey":"BZCALJIHZVNMGJ-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASIGLIFAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasiglifam","Fasiglifam hemihydrate","TAK-875","Tak-875 anhydrous"],"crossReferences":{"drugbank":["DB12491"]},"childChemblIds":["CHEMBL2047171","CHEMBL2047159"],"linkedTargets":{"rows":["ENSG00000126266"],"count":1},"linkedDiseases":{"rows":["HP_0011015","MONDO_0005148","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1835919","canonicalSmiles":"Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2","inchiKey":"GEVVQZHMFVFGLN-HDJSIYSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04620110","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04620110","PF-4620110","Pf-04620110"],"crossReferences":{"drugbank":["DB14887"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL191141","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccc(Cl)cc1","inchiKey":"BWRRXOIACQYNEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191141","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08282"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL202701","canonicalSmiles":"Nc1nccc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"DBZQFUNLCALWDY-PNHWDRBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Deazaadenosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Deazaadenosine"],"crossReferences":{"drugbank":["DB04546"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL207538","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AURFZBICLPNKBZ-SYBPFIFISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BREXANOLONE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zulresso"],"synonyms":["Allopregnan-3.alpha.-ol-20-one","Allopregnanolone","Allotetrahydroprogesterone","Brexanolone","SAGE-547","SGE-102"],"crossReferences":{"DailyMed":["brexanolone"],"PubChem":["144205595","26756639"],"drugbank":["DB11859"],"chEBI":["50169"]},"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0008526","MONDO_0002050","EFO_0007453","MONDO_0004975","EFO_0001358","MONDO_0043510","MONDO_0007079","EFO_0003108","Orphanet_93256"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for postpartum depression and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL207729","canonicalSmiles":"CC#CCOc1ccc(S(=O)(=O)N2CCSC(C)(C)[C@@H]2C(=O)NO)cc1","inchiKey":"CVZIHNYAZLXRRS-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207729","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07964"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104415","canonicalSmiles":"CO/N=C1\\C[C@]2(C[C@@H]3C[C@@H](C/C=C(\\C)C[C@@H](C)/C=C/C=C4\\CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C","inchiKey":"YZBLFMPOMVTDJY-LSGXYNIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXIDECTIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CL 301,423","CL-301,423","CL-301423","Moxidectin","Moxidectin for veterinary use","NSC-760424"],"crossReferences":{"DailyMed":["moxidectin"],"drugbank":["DB11431"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for helminthiasis and onchocerciasis and has 3 investigational indications."}
{"id":"CHEMBL2104840","canonicalSmiles":"O=P([O-])(O)O.O=P([O-])([O-])O.O=S(=O)([O-])[O-].[Cl-].[Cl-].[K+].[K+].[Mg+2].[Na+].[Na+].[Na+]","inchiKey":"DWAYUNSAAKQFJZ-UHFFFAOYSA-G","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTALYTE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tis-u-sol"],"synonyms":["Pentalyte"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104900","canonicalSmiles":"O=C(OCCOCCN1CCCCC1)N1c2ccccc2Sc2cccnc21","inchiKey":"DTVJXCOMJLLMAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPAZETHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-254","Pipazetate","Pipazethate","SK&F 70230-A","SO 15,874","SQ 15,874","SQ-15874"],"crossReferences":{"drugbank":["DB08796"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105373","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"OZZAYJQNMKMUSD-DMISRAGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREGNENOLONE SUCCINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Formula 405"],"synonyms":["Arthenolone","Enelone","NSC-1616","NSC-18158","NSC-759188","Pregnenolone","Pregnenolone succinate"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2105544","canonicalSmiles":"CC(Cc1ccccc1)/N=C/C(Cl)(Cl)Cl","inchiKey":"VBZDETYCYXPOAK-OVCLIPMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPHECLORAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amfecloral","Amphecloral"],"crossReferences":{"drugbank":["DB08924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106123","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Ca+2].[Ca+2].[Ca+2]","inchiKey":"FNAQSUUGMSOBHW-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM CITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citracal"],"synonyms":["Calcimax","Calcium (as citrate)","Calcium citrate","Calcium citrate anhydrous","Calcium citrate tetrahydrate","E-333(III)","INS NO.333(III)","INS-333(III)","Tricalcium citrate tetrahydrate"],"crossReferences":{"DrugCentral":["4479"],"drugbank":["DB11093"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2106633","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Mg+2]","inchiKey":"HQKMJHAJHXVSDF-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM STEARATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibasic magnesium stearate","Magnesii stearas","Magnesium palmitostearate","Magnesium stearate","Magnesium stearate g"],"crossReferences":{"drugbank":["DB14077"],"chEBI":["9254"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106829","canonicalSmiles":"Cc1ccccc1-n1c(C)nc2ccccc2c1=O.Cl","inchiKey":"KJUHIXIWKSVBKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAQUALONE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL282052","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Misuse"],"year":1984},"tradeNames":["Optimil","Parest"],"synonyms":["Methaqualone hcl","Methaqualone hydrochloride","NSC-75892"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1984 due to Misuse."}
{"id":"CHEMBL2106972","canonicalSmiles":"O=C(Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1)c1cccs1","inchiKey":"SSLHKNBKUBAHJY-HDJSIYSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NELTENEXINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neltenexine"],"crossReferences":{"drugbank":["DB13239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108081","drugType":"Protein","blackBoxWarning":false,"name":"TRAFERMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fiblast"],"synonyms":["CAB-2001","Trafermin"],"linkedTargets":{"rows":["ENSG00000066468"],"count":1},"linkedDiseases":{"rows":["EFO_1001459","EFO_0009472","EFO_0000649"],"count":3},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108195","drugType":"Unknown","blackBoxWarning":false,"name":"BLOOD CELLS, RED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Blood cells, human red","Blood cells, red","Human red blood cells","Red blood cells"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108326","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ALICAFORSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alicaforsen"],"linkedTargets":{"rows":["ENSG00000090339"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000384","EFO_0003767","EFO_0003921"],"count":4},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108378","drugType":"Antibody","blackBoxWarning":false,"name":"EDOBACOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edobacomab","XMMEN-0E5","Xomen-E5"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108632","drugType":"Unknown","blackBoxWarning":false,"name":"PLATELETS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Homo sapiens platelet, allogenic","Human platelet, allogenic","Platelets","Platelets allogenic","Platelets human allogenic"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108809","drugType":"Antibody","blackBoxWarning":false,"name":"SULESOMAB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Leukoscan"],"synonyms":["IMMU-MN3","Sulesomab","Technetium (99mtc) sulesomab","Technetium tc 99m sulesomab"],"description":"Antibody drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109482","drugType":"Antibody","blackBoxWarning":false,"name":"BI-505","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-505","Bi-505"],"linkedTargets":{"rows":["ENSG00000090339"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109513","drugType":"Antibody","blackBoxWarning":false,"name":"PD-360324","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-360324","Pd-360324"],"linkedTargets":{"rows":["ENSG00000184371"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_0000685","EFO_0001075","MONDO_0015686","EFO_1000251","DOID_13406","EFO_0000311"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109607","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-8968","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-8968","Medi-8968"],"linkedTargets":{"rows":["ENSG00000115594"],"count":1},"linkedDiseases":{"rows":["EFO_1000710","EFO_0000341"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL215344","canonicalSmiles":"c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1","inchiKey":"JYJAEHAURXXPSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL215344","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03672"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218893","canonicalSmiles":"CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.O=S(=O)(O)O","inchiKey":"VPCOODFYDJWLHD-YMZXMBPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEDORADRINE SULFATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111083","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bedoradrine sulfate","Bedoradrine sulphate","KUR-1246","MN-221"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0008590","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2219417","canonicalSmiles":"O=CN(CC(O)CN(C=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"BFVVDRUCXCIALU-UHFFFAOYSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"IOFORMINOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AN-113111","FEK-256-062","GE-145","Ioforminol"],"crossReferences":{"drugbank":["DB12439"]},"description":"Unknown drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2286758","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC","inchiKey":"BIABMEZBCHDPBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2286758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02043"],"chEBI":["60724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2325014","canonicalSmiles":"Nc1[nH]ncc1-c1cc(Cl)ccc1Oc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl","inchiKey":"ZYSCOUXLBXGGIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2325014","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL236593","canonicalSmiles":"O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(O)nc3ncccc32)CC1","inchiKey":"CGDZXLJGHVKVIE-DNVCBOLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELCAGEPANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0974","MK0974","Mk-0974","Telcagepant"],"crossReferences":{"Wikipedia":["Telcagepant"],"drugbank":["DB12228"]},"childChemblIds":["CHEMBL2105656"],"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 1 investigational indication."}
{"id":"CHEMBL236718","canonicalSmiles":"Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CC(F)(F)C[C@@H]32)cc1","inchiKey":"QJSMFUTULGSHNQ-ZOBUZTSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL236718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07638"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2368861","canonicalSmiles":"CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5.Cl","inchiKey":"UAIXRPCCYXNJMQ-HPRIMLMLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPRENORPHINE HYDROCHLORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL511142","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Belbuca","Buprenex","Buprenorphine hydrochloride","Espranor","Gabup","Natzon","Prefibin","Probuphine","Subutex"],"synonyms":["Anorfin","Buprederm","Buprenorphine hcl","Buprenorphine hydrochloride","Buprenorphine hydrochloride ciii","Buprex","CL 112,302","CL-112302","Finibron","Lepetan","M-6029","NIH 8805","NIH-8805","Nopan","RX 6029-M HCL","RX-6029-M HCL","SCH-028444","UM 952","UM-952","Vetergesic"],"crossReferences":{"DailyMed":["buprenorphine%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0003890","EFO_0005611"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL253951","canonicalSmiles":"O=C(O/N=C/c1ccc(O)cc1)C1CCCCC1","inchiKey":"YWZBYSBZDQWXGQ-XNTDXEJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253951","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08333"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL291678","canonicalSmiles":"NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)C[C@@H](c2ccc(CP(=O)(O)O)cc2)/C=C/C[C@@H](Cc2cccc3ccccc23)CNC1=O","inchiKey":"RHYFMOCFCFUTNH-GZNVFMSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL291678","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL307697","canonicalSmiles":"O=[N+]([O-])c1ccc(NN=C(c2ccc(O)cc2)c2ccc(O)cc2)c([N+](=O)[O-])c1","inchiKey":"YOQPCWIXYUNEET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIVIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-007","Sivifene"],"crossReferences":{"drugbank":["DB05686"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL316040","canonicalSmiles":"COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1","inchiKey":"XYKWNRUXCOIMFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPOXALIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORF 20485","ORF-20485","RWJ 20485","RWJ-20485","Tepoxalin","Zubrin"],"crossReferences":{"PubChem":["170466265"],"drugbank":["DB11466"],"chEBI":["76277"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185220","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O","inchiKey":"UGMCXQCYOVCMTB-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185220","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206641"],"drugbank":["DB01375"],"chEBI":["31197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3221419","canonicalSmiles":"C/C=C\\C=C\\[C@@H]1O[C@](O)([C@H](CC)C(=O)NC/C=C/C=C(\\C)[C@@H](OC)[C@@H](C)[C@@H]2O[C@H](/C=C/C=C/C=C(\\C)C(=O)c3c(O)ccn(C)c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)C1(C)C","inchiKey":"NTAHMPNXQOYXSX-WKSONYIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3221419","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3542265","canonicalSmiles":"CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1","inchiKey":"IHIWYQYVBNODSV-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2452473","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2452473","LY2452473","Ly2452473","OPK-88004","TT-701"],"crossReferences":{"drugbank":["DB12573"]},"childChemblIds":["CHEMBL3542296"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0004234","EFO_0000284","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3544941","drugType":"Small molecule","blackBoxWarning":false,"name":"RG7185","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO5271983","Rg7185"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544961","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-853520","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi-853520"],"linkedTargets":{"rows":["ENSG00000169398"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544985","canonicalSmiles":"COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[n-]c2=O)cc1C(C)(C)C.O.[Na+]","inchiKey":"SJHKKWUESHNTBB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DASABUVIR SODIUM","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3137312","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dasabuvir sodium","Dasabuvir sodium anhydrous"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for chronic hepatitis c virus infection and hepatitis c virus infection."}
{"id":"CHEMBL3545250","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2269557","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2269557","GSK2269557","Gsk-2269557","Nemiralisib hydrochloride"],"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545396","canonicalSmiles":"COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1","inchiKey":"CSGQVNMSRKWUSH-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-690514","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms 6690514","Bms 690514","Bms-690514"],"crossReferences":{"drugbank":["DB11665"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000178568","ENSG00000141736"],"count":6},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0003060","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL360998","canonicalSmiles":"CN(C)Cc1ccc(-c2cccnc2)o1","inchiKey":"PJHSLLRNPASXIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360998","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07609"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL365845","canonicalSmiles":"CC(C)c1c(OC#CC2CC2)c2cc(F)ccc2[nH]c1=O","inchiKey":"YVJFHKQYMKKIHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL365845","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07864"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL368238","canonicalSmiles":"CC(C)N1CCC(NC(=O)c2cc3ccccc3n2CC(=O)Nc2ccc(Cl)cc2)CC1","inchiKey":"BDLMBQRBNPDCSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL368238","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707383","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"MONGERSEN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GED-0301","GED-0301 SODIUM","Mongersen sodium"],"linkedTargets":{"rows":["ENSG00000101665"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000384"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707409","canonicalSmiles":"N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1.O=C(O)CCCCC(=O)O","inchiKey":"CEGWJIQFBNFMHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITACITINIB ADIPATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3622820","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-039110 ADIPATE","INCB039110 adipate","Itacitinib adipate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707448","canonicalSmiles":"C1N2CN3CN1CN(C2)C3.N#C[S-].N#C[S-].[Ca+2]","inchiKey":"MYCYALXPHWPBMJ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM HEXAMINE THIOCYANATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201270","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium hexamine thiocyanate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL376897","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"LZCOQTDXKCNBEE-IKIFYQGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHSCOPOLAMINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-n-methylscopolamine","Methscopolamine cation","Methscopolamine ion","Methylscopolamine","N-methylhyoscine","N-methylscopolamine"],"crossReferences":{"DailyMed":["methscopolamine%20bromide"],"Wikipedia":["Methylscopolamine_bromide"],"drugbank":["DB11315"]},"childChemblIds":["CHEMBL1506225","CHEMBL1354199"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282","EFO_0005758"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL406819","canonicalSmiles":"O=[N+]([O-])/N=C1\\NCCN1Cc1ccc(Cl)nc1","inchiKey":"YWTYJOPNNQFBPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDACLOPRID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidacloprid"],"crossReferences":{"PubChem":["144204850","144206909","144211345","170465741","26757127","29217927","50086524"],"Wikipedia":["Imidacloprid"],"drugbank":["DB11421"],"chEBI":["5870"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408500","canonicalSmiles":"CCCCCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO","inchiKey":"FTSCEGKYKXESFF-LXTVHRRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-(N-Nonyl)Deoxynojirimycin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-(N-Nonyl)Deoxynojirimycin","N-Nonyl 1-Deoxynojirimycin","N-Nonyl-Deoxynojirimycin","N-Nonyldeoxynojirimycin"],"crossReferences":{"PubChem":["50130528"],"drugbank":["DB08283"],"chEBI":["76399"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL412272","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C","inchiKey":"AWDRATDZQPNJFN-VAYUFCLWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAURODEOXYCHOLIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deoxy Cholate","Deoxycholyltaurine","HY-209","HY209","Hy209","J339.140J","Taurodeoxycholic acid","Taurodesoxycholic acid","Tudcabil"],"crossReferences":{"Wikipedia":["Taurodeoxycholic_acid"],"chEBI":["9410"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4175981","canonicalSmiles":"CC(C)(C)[C@@H](CO)NC(=O)c1nn(-c2c[n+]([O-])ccn2)c2c1C[C@@H]1C[C@H]21","inchiKey":"ACSQLTBPYZSGBA-GMXVVIOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLORINAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD-371","APD371","Apd371","Olorinab"],"crossReferences":{"drugbank":["DB14998"]},"linkedTargets":{"rows":["ENSG00000188822"],"count":1},"linkedDiseases":{"rows":["HP_0002027","EFO_0000555","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL428647","canonicalSmiles":"CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C","inchiKey":"RCINICONZNJXQF-MZXODVADSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PACLITAXEL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"crossReferences":{"DailyMed":["paclitaxel"],"PubChem":["124893045","144205660","418145","56463361"],"drugbank":["DB01229"],"chEBI":["45863"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_1000419","EFO_1000403","EFO_0011061","EFO_0000365","EFO_0003859","EFO_0000558","EFO_0000756","EFO_0000681","EFO_1000231","EFO_0005952","EFO_0000308","MONDO_0044704","EFO_0002917","EFO_1000984","EFO_1001951","EFO_1001952","EFO_0000178","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_1000251","MONDO_0001528","EFO_0008528","EFO_1000532","EFO_0000676","EFO_0000514","MONDO_0004116","MONDO_0018352","MONDO_0002715","MONDO_0002601","EFO_0002618","EFO_1001931","EFO_0005922","EFO_0000180","EFO_1001512","EFO_1001968","MONDO_0004986","MONDO_0008315","EFO_0005221","EFO_0002496","MONDO_0001879","EFO_1001967","MONDO_0002691","EFO_1000489","Orphanet_398934","MONDO_0000544","MONDO_0018201","EFO_0006818","EFO_0008524","EFO_0004284","EFO_0000574","EFO_0001378","EFO_1000796","EFO_1000412","MONDO_0018171","MONDO_0002876","EFO_1001465","MONDO_0007254","MONDO_0005271","EFO_0000284","EFO_0004252","MONDO_0002877","MONDO_0020654","MONDO_0001056","MONDO_0021043","MONDO_0002158","MONDO_0022394","EFO_0003968","EFO_0003100","EFO_0000183","EFO_0000707","MONDO_0021251","EFO_0000616","EFO_0003897","EFO_0005088","EFO_0006859","EFO_0000186","EFO_0002916","Orphanet_59305","EFO_1000435","EFO_0007483","Orphanet_44890","EFO_0001645","MONDO_0007576","EFO_0007535","EFO_1001953","MONDO_0021657","EFO_0003843","EFO_1001961","EFO_1001471","EFO_0000304","MONDO_0056806","MONDO_0002120","MONDO_0021148","EFO_0002517","MONDO_0011962","EFO_0000764","EFO_0000702","EFO_0000199","MONDO_0002367","MONDO_0024880","EFO_1001927","EFO_0000519","EFO_0004265","MONDO_0044926","EFO_0005232","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_0004281","EFO_1001958","EFO_0000571","MONDO_0000956","EFO_1000657","MONDO_0004222","EFO_0000228","EFO_0000565","EFO_0006462","EFO_0000389","EFO_1001331","EFO_0000182","MONDO_0005411","MONDO_0003000","MONDO_0021115","EFO_0001416","Orphanet_145","EFO_0003893","MONDO_0004658","EFO_0000466","MONDO_0002108","EFO_0004224","MONDO_0008170","MONDO_0004669","EFO_0006772","EFO_0009708","EFO_0000294","EFO_1000576","EFO_0001061","MONDO_0044787","EFO_0003868","EFO_1001100","EFO_1000238","EFO_0005537","EFO_0000233","EFO_1000252","EFO_0000432","EFO_0006544","EFO_1000613","EFO_1000358","EFO_0000563","MONDO_0021355","EFO_1000172","EFO_0002938","MONDO_0015686","MONDO_0004192","EFO_1000236","EFO_0004230","EFO_0000708","MONDO_0002087","MONDO_0024879","EFO_0000305","MONDO_0020657","EFO_1000357","MONDO_0001187","EFO_0003826","EFO_1001480","EFO_1000044","EFO_1000043","EFO_0003860","EFO_0006352","EFO_1000242","EFO_0000673","EFO_0004272","EFO_1001963","EFO_1000042","EFO_0002617","EFO_1000158","EFO_0002914","EFO_1000253","MONDO_0001402","EFO_0000685","EFO_1000616","EFO_0006318","EFO_0000503","EFO_0003875","EFO_0000478","EFO_0000556","EFO_0000313","EFO_0004243","EFO_0003060","EFO_0000311","EFO_1001153","EFO_0003863","EFO_1000581","EFO_0010282","EFO_0006861","EFO_0000095","EFO_0002892","EFO_0004142","MONDO_0003219","EFO_0000612","EFO_1000081","EFO_0004149","EFO_0003833","EFO_0000691","EFO_0000181","EFO_0003050","MONDO_0001325","EFO_1000494","EFO_1000233"],"count":210},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 8 approved and 138 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297407","canonicalSmiles":"COC(=O)[C@H]1[C@@H](c2ccc(F)cc2)C[C@@H]2CC[C@H]1N2C/C=C/[123I]","inchiKey":"GTQLIPQFXVKRKJ-HYRAKNMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTROPANE I-123","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4301492","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(123i)altropane","123i-altropane","Altropane i-123","Iacft 123i-labeled form","NAV-5001","NAV-5001 I-123","NAV5001","Nav5001"],"crossReferences":{"drugbank":["DB15144"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297439","canonicalSmiles":"COCN1C(=O)N(COC)C(=O)C(c2ccccc2)(c2ccccc2)C1=O","inchiKey":"RRFBTKHQZRCRSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T-2000","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T-2000","T2000"],"crossReferences":{"drugbank":["DB11654"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297746","drugType":"Unknown","blackBoxWarning":false,"name":"ENADENOTUCIREV","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enadenotucirev"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297749","drugType":"Unknown","blackBoxWarning":false,"name":"EPOFOLATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-753493","BMS753493","Epofolate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298062","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VILTOLARSEN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Viltepso"],"synonyms":["NCNP-01","NS-065","NS-065/NCNP-01","Ns-065/ncnp-01","Viltolarsen"],"linkedTargets":{"rows":["ENSG00000198947"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","Orphanet_98473"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for duchenne muscular dystrophy and muscular dystrophy."}
{"id":"CHEMBL4298066","drugType":"Unknown","blackBoxWarning":false,"name":"ONL-1204","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONL1204","Onl-1204","Onl1204"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298179","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TEPRASIRAN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Teprasiran sodium"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4298195","drugType":"Antibody","blackBoxWarning":false,"name":"NARSOPLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Masp-2 antibody","Narsoplimab","OMS-721","OMS00620646","OMS620646","OMS721"],"linkedTargets":{"rows":["ENSG00000009724"],"count":1},"linkedDiseases":{"rows":["EFO_0005761","Orphanet_2134","MONDO_0100096","EFO_0004194","Orphanet_329918"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4299850","canonicalSmiles":"CN1CC2CCCC(C1)C2OC(=O)C(O)(c1ccccc1)C1CCCC1","inchiKey":"ROZOEEGFKDFEFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENCYNONATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-bencynonatine"],"childChemblIds":["CHEMBL4297319"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL443605","canonicalSmiles":"CCCCCCc1ccc(O)cc1O","inchiKey":"WFJIVOKAWHGMBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXYLRESORCINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sucrets"],"synonyms":["E-586","Hexylresorcinol","INS NO.586","INS-586"],"crossReferences":{"PubChem":["144204653","144209461","144210675","170465471","17388779","26747321","26752939","56436657","68346"],"Wikipedia":["Hexylresorcinol"],"drugbank":["DB11254"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL44875","drugType":"Small molecule","blackBoxWarning":false,"name":"BIBROCATHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bibrocathin","Bibrocathol","Bismucatebrol","Cabis bromatum","Noviform"],"crossReferences":{"Wikipedia":["Bibrocathol"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594347","drugType":"Protein","blackBoxWarning":false,"name":"CLERVONAFUSP ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clervonafusp alfa","VAL-1221","Val-1221"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594394","canonicalSmiles":"O=C([O-])CCCO.O=C([O-])CCCO.[Mg+2]","inchiKey":"QWZIZKOBUUSCLO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM OXYBATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Magnesium oxybate","Oxybate magnesium"],"crossReferences":{"DailyMed":["magnesium%20oxybate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL4594437","canonicalSmiles":"Cc1cccc(N2CCN(CCc3ccc4ccccc4n3)CC2)c1","inchiKey":"UJNWGFBJUHIJKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENTHAQUINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COMPOUND-7173","Centhaquine","PMZ-2010","PMZ2010"],"childChemblIds":["CHEMBL4650227"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL460026","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O","inchiKey":"JAZBEHYOTPTENJ-JLNKQSITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOSAPENT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["All-cis-fatty acid 20:5 omega-3","C20:5 (n-3)","EPA 45G","Eicosapentaenoate","Eicosapentaenoic acid","Eicosapentaenoic acid (c20:5 n3)","Icosapent","Incromega e 7010sr","Omega-3 marine triglycerides","Ropufa 70","Timnodonic acid"],"crossReferences":{"PubChem":["144205544","26754924","26754925","50110832"],"Wikipedia":["Eicosapentaenoic_acid"],"drugbank":["DB00159"],"chEBI":["28364"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 47 investigational indications."}
{"id":"CHEMBL4650291","drugType":"Antibody","blackBoxWarning":false,"name":"FPA144","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FPA144","Fpa144"],"linkedTargets":{"rows":["ENSG00000066468"],"count":1},"linkedDiseases":{"rows":["MONDO_0001056"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802166","drugType":"Unknown","blackBoxWarning":false,"name":"BLU-5937","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BLU-5937","Blu-5937"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802206","drugType":"Unknown","blackBoxWarning":false,"name":"FK-962","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FK-962","FK962","Fk-962","Fk962"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL488994","canonicalSmiles":"COc1c(O)c(OC)c2oc(-c3ccccc3O)cc(=O)c2c1O","inchiKey":"JWOKGWICZPPYPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL488994","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13983"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494753","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O","inchiKey":"JKKFKPJIXZFSSB-CBZIJGRNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRONE SULFURIC ACID","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Estrone Sulphate"],"crossReferences":{"DailyMed":["estropipate"],"PubChem":["11112590"],"Wikipedia":["Estrone_sulfate"],"drugbank":["DB04574"],"chEBI":["17474"]},"childChemblIds":["CHEMBL1200980","CHEMBL1546237","CHEMBL2106240"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0004266","EFO_1000096","EFO_0003882","EFO_0003922"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 5 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL497318","canonicalSmiles":"CCCCCc1cc(O)c(C/C=C(\\C)CCC=C(C)C)c(O)c1","inchiKey":"QXACEHWTBCFNSA-SFQUDFHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABIGEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannabigerol"],"crossReferences":{"Wikipedia":["Cannabigerol"],"drugbank":["DB14734"],"chEBI":["69477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL499808","canonicalSmiles":"CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O","inchiKey":"JYIKNQVWKBUSNH-OGZDCFRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASPOFUNGIN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cancidas"],"synonyms":["Caspofungin","Caspofungin acetate","L-743,872","L-743872","MK-991"],"crossReferences":{"DailyMed":["caspofungin%20acetate"],"Wikipedia":["Caspofungin"],"chEBI":["474180"]},"childChemblIds":["CHEMBL4297142"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 10 investigational indications."}
{"id":"CHEMBL502109","canonicalSmiles":"CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1.[Cl-]","inchiKey":"XIWFQDBQMCDYJT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"BENZALKONIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1187417","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capitol","Dermax therapeutic","Drapolene","Roccal","Zephiran chloride"],"synonyms":["Alpagelle","Benzalkonii chloridum","Benzalkonium chloride","Hyamine 3500","NSC-758480","Pentonium","Zephiran"],"crossReferences":{"PubChem":["26748812"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL504652","canonicalSmiles":"c1cncc(N2CCC3(CCCN3)C2)c1","inchiKey":"NXIPMBQVNTWEEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TC-2216","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TC-2216","Tc-2216"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0005230"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL50588","canonicalSmiles":"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21","inchiKey":"AUVVAXYIELKVAI-CKBKHPSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-emetine","6',7',10,11-tetramethoxyemetan","Cephaeline methyl ether","Emetin","Emetine","Emetinum","GNF-Pf-196","NSC-33669","TCMDC-125531"],"crossReferences":{"PubChem":["144204452","170465705","29215025","50104287","50104288","90341404"],"Wikipedia":["Emetine"],"drugbank":["DB13393"],"chEBI":["4781"]},"childChemblIds":["CHEMBL493439","CHEMBL1255782","CHEMBL513000"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL530","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](/N=C/N3CCCCCC3)C(=O)N2[C@H]1C(=O)O","inchiKey":"BWWVAEOLVKTZFQ-ISVUSNJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMDINOCILLIN","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Coactin","Selexidin"],"synonyms":["Amdinocillin","FL 1060","FL-1060","Mecillinam","RO 10-9070","RO-10-9070"],"crossReferences":{"PubChem":["144205762","170465354"],"Wikipedia":["Mecillinam"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for bacterial disease."}
{"id":"CHEMBL54893","canonicalSmiles":"CC(C)=CCOc1cc(NC(=S)c2ccoc2C)ccc1Cl","inchiKey":"YZHIXLCGPOTQNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UC 781","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UC-781","Uc 781"],"crossReferences":{"PubChem":["515904"],"drugbank":["DB05871"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL593830","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"NGTCPFGWXMBZEP-NQQHDEILSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593830","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03488"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL598172","canonicalSmiles":"COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1-c1c(Br)cnn1C","inchiKey":"COSPVUFTLGQDQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NELOTANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD-125","APD125","Apd-125","Nelotanserin"],"crossReferences":{"drugbank":["DB12555"]},"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0006792","EFO_0004698","HP_0000738"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL610","canonicalSmiles":"NCCc1ccccc1","inchiKey":"BHHGXPLMPWCGHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenethylamine","Phenylethylamine"],"crossReferences":{"PubChem":["26756723","49718670"],"Wikipedia":["Phenethylamine"],"drugbank":["DB04325"],"chEBI":["18397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL634","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1","inchiKey":"IDBPHNDTYPBSNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALFENTANIL","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Afentanyl","Alfentanil","Alfentanyl","IDS-NA-014","R-39209","R-39209-"],"crossReferences":{"Wikipedia":["Alfentanil"],"drugbank":["DB00802"],"chEBI":["2569"]},"childChemblIds":["CHEMBL1200531"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0004799","EFO_0010282","EFO_0009447","MONDO_0008903","EFO_0003843","HP_0000713"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986. This drug has a black box warning from the FDA."}
{"id":"CHEMBL80830","canonicalSmiles":"CC(C)(S)C(=O)N[C@@H](CS)C(=O)O","inchiKey":"VUAFHZCUKUDDBC-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCILLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucilant","Bucillamine"],"crossReferences":{"PubChem":["144206698"],"Wikipedia":["Bucillamine"],"drugbank":["DB12160"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL84446","canonicalSmiles":"NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)c2cc(F)ccc2O1","inchiKey":"WAAPEIZFCHNLKK-UFBFGSQYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIDARESTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aldos","Fidarestat"],"crossReferences":{"PubChem":["144206034"],"drugbank":["DB02021"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL869","canonicalSmiles":"NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1","inchiKey":"IAIWVQXQOWNYOU-FPYGCLRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROFURAZONE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Actin-n","Furacin","Furacine","Furazone","Nitrofural","Nitrofurazone"],"synonyms":["Furacilin","NSC-1602","NSC-2100","Nitrofural","Nitrofurazone"],"crossReferences":{"PubChem":["144204548","144210186","144213996","170464946","17389801","26747226","26752739"],"TG-GATEs":["65"],"Wikipedia":["Nitrofural"],"drugbank":["DB00336"]},"childChemblIds":["CHEMBL1204113"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1945 and has 3 approved and 2 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL927","canonicalSmiles":"C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\O)c3csc(N)n3)[C@H]2SC1","inchiKey":"RTXOFQZKPXMALH-GHXIOONMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFDINIR","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefdinir","Cefzon","Omnicef"],"synonyms":["BMY-28488","CI-983","Cefdinir","Cefdinir anhydrous","Cefzon","FK 482","FK-482","NSC-758926"],"crossReferences":{"DailyMed":["cefdinir"],"PubChem":["56422579"],"Wikipedia":["Cefdinir"],"drugbank":["DB00535"],"chEBI":["3485"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 7 approved and 3 investigational indications."}
{"id":"CHEMBL9417","canonicalSmiles":"N[C@@H](Cc1ccccc1)C(O)[C@@H](N)Cc1ccccc1","inchiKey":"GZBLEJZADHZBBZ-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL9417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07575"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL95","canonicalSmiles":"Nc1c2c(nc3ccccc13)CCCC2","inchiKey":"YLJREFDVOIBQDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACRINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tacrinal","Tacrine"],"crossReferences":{"PubChem":["104171104","11110734","11113824","124879172","124879174","144203624","144212594","170465420","26755281","90341647"],"TG-GATEs":["60"],"Wikipedia":["Tacrine"],"drugbank":["DB00382"],"chEBI":["45980"]},"childChemblIds":["CHEMBL1677","CHEMBL1337960"],"linkedTargets":{"rows":["ENSG00000087085","ENSG00000114200"],"count":2},"linkedDiseases":{"rows":["EFO_0002610","HP_0000726"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for dementia and has 1 investigational indication."}
{"id":"CHEMBL95097","canonicalSmiles":"Cc1cc(Br)c(O)c(-c2nc3cc(C(=N)N)ccc3[nH]2)c1","inchiKey":"XKCHOMIJYLHXLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL95097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
